Joshi A, Bhaskar N, Pearson J
Cancers (Basel). 2025; 17(2).
PMID: 39858043
PMC: 11763869.
DOI: 10.3390/cancers17020260.
Kobayashi N, Sunaga N, Yatomi M, Wakamatsu I, Muto S, Ikota H
Thorac Cancer. 2024; 16(2):e15512.
PMID: 39731296
PMC: 11735726.
DOI: 10.1111/1759-7714.15512.
Li X, Luan X, Zhang M, Wang R, Guo J, Lv J
Front Immunol. 2024; 15:1439033.
PMID: 39234244
PMC: 11371601.
DOI: 10.3389/fimmu.2024.1439033.
Yang Y, Fan S
Chin Med J Pulm Crit Care Med. 2024; 2(1):42-47.
PMID: 39170959
PMC: 11332903.
DOI: 10.1016/j.pccm.2023.10.005.
Zhong J, Li X, Wang Z, Duan J, Li W, Zhuo M
J Natl Cancer Cent. 2024; 1(4):153-162.
PMID: 39036802
PMC: 11256618.
DOI: 10.1016/j.jncc.2021.11.001.
Anaplastic thyroid carcinoma transformation in a patient with advanced non-small cell lung cancer treated with PD-1 therapy: A case report.
Kataoka Y, Fujita T, Hanaoka J
Respir Med Case Rep. 2024; 50:102070.
PMID: 38903654
PMC: 11187231.
DOI: 10.1016/j.rmcr.2024.102070.
Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From -Mutant NSCLC Informs Potential Therapeutic Targets.
Zhang B, Lewis W, Stewart C, Morris B, Solis L, Serrano A
JTO Clin Res Rep. 2024; 5(2):100623.
PMID: 38357092
PMC: 10864847.
DOI: 10.1016/j.jtocrr.2023.100623.
Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy.
Zeng J, Ding X, Ding J, Wang X
Front Immunol. 2023; 14:1275957.
PMID: 38022621
PMC: 10646212.
DOI: 10.3389/fimmu.2023.1275957.
Expression of -mutant proteins and genomic evolution in -mutant transformed small cell lung cancer.
Zhang S, Zhang C, Chen Y, Li Y, Xie Z, Zhang X
J Thorac Dis. 2023; 15(9):4620-4635.
PMID: 37868836
PMC: 10586967.
DOI: 10.21037/jtd-23-161.
Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer.
Kowash R, Akbay E
Front Immunol. 2023; 14:1130358.
PMID: 37033953
PMC: 10079876.
DOI: 10.3389/fimmu.2023.1130358.
Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report.
Yang M, Yu J, Cai C, Li W
Front Oncol. 2022; 12:1029282.
PMID: 36568150
PMC: 9768476.
DOI: 10.3389/fonc.2022.1029282.
Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases.
Liu H, Chen L, Zhang Z, Wang N, Zhuang S, Chen H
Front Oncol. 2022; 12:1022705.
PMID: 36439460
PMC: 9683475.
DOI: 10.3389/fonc.2022.1022705.
A Tale of Two Histologies: Dissecting the Biology of Lineage Transformation in Lung Cancer.
Meador C, Lovly C
Cancer Discov. 2022; 11(12):2962-2964.
PMID: 35363868
PMC: 8988434.
DOI: 10.1158/2159-8290.CD-21-1222.
Is transformed small cell lung cancer (SCLC) different from SCLC?.
Park C, Oh I, Kim Y
Transl Cancer Res. 2022; 8(2):346-349.
PMID: 35116765
PMC: 8799057.
DOI: 10.21037/tcr.2019.03.22.
Small cell transformation of non-small cell lung cancer under immunotherapy: Case series and literature review.
Imakita T, Fujita K, Kanai O, Okamura M, Hashimoto M, Nakatani K
Thorac Cancer. 2021; 12(22):3062-3067.
PMID: 34622569
PMC: 8590890.
DOI: 10.1111/1759-7714.14180.
mRNA Network: Solution for Tracking Chemotherapy Insensitivity in Small-Cell Lung Cancer.
Chen P, Wu S, Yu J, Tang X, Dai C, Qi H
J Healthc Eng. 2021; 2021:2105176.
PMID: 34621500
PMC: 8492269.
DOI: 10.1155/2021/2105176.
Small cell lung cancer transformation during antitumor therapies: A systematic review.
Chai X, Zhang X, Li W, Chai J
Open Med (Wars). 2021; 16(1):1160-1167.
PMID: 34435141
PMC: 8359904.
DOI: 10.1515/med-2021-0321.
Case Report: Transformation From Non-Small Cell Lung Cancer to Small Cell Lung Cancer During Anti-PD-1 Therapy: A Report of Two Cases.
Shen Q, Qu J, Sheng L, Gao Q, Zhou J
Front Oncol. 2021; 11:619371.
PMID: 34094904
PMC: 8176117.
DOI: 10.3389/fonc.2021.619371.
Pathology and Classification of SCLC.
Raso M, Bota-Rabassedas N, Wistuba I
Cancers (Basel). 2021; 13(4).
PMID: 33669241
PMC: 7919820.
DOI: 10.3390/cancers13040820.
Evasion of Innate Immunity Contributes to Small Cell Lung Cancer Progression and Metastasis.
Zhu M, Huang Y, Bender M, Girard L, Kollipara R, Eglenen-Polat B
Cancer Res. 2021; 81(7):1813-1826.
PMID: 33495232
PMC: 8137539.
DOI: 10.1158/0008-5472.CAN-20-2808.
